COMMUNIQUÉS West-GlobeNewswire

Hemispherx Announces Progress Toward Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center
13/05/2019
OCALA, Fla., May 13, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and [...]
Bellerophon to Present Additional Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at American Thoracic Society 115th International Conference
13/05/2019
Results to be Presented in Late-Breaking Abstract as an Oral Presentation Company will Also Present a Corporate Overview and Update on its PH-ILD Program at Respiratory Innovation Summit WARREN, N.J., May 13, 2019 ( [...]
Aptose to Present at May Investor Conferences
13/05/2019
SAN DIEGO and TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs
13/05/2019
Potential first-in-class, oral specific orexin- 2 inhibitor demonstrates statistically significant improvement in MADRS scores at 6 weeks compared to placebo Well tolerated, with adverse events similar to or lower than [...]
iTeos Therapeutics to Present at UBS Global Healthcare Conference
13/05/2019
iTeos Therapeutics to Present at UBS Global Healthcare Conference Gosselies, Belgium and Cambridge, MA – May 13, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel cancer [...]
Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results
13/05/2019
ROCKVILLE, Md., May 13, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]
HempAmericana Commences Bottling on Full Spectrum Distillate CBD in Maine Laboratory
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is pleased to announce that it has commenced bottling 500mg and 1000mg full spectrum CBD [...]
resTORbio to Present RTB101 Phase 2b Clinical Trial Data at American Thoracic Society 2019 International Conference
13/05/2019
BOSTON, May 13, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC) today announced that it will present additional results from the Phase 2b trial evaluating RTB101 (dactolisib), an oral, selective, and potent [...]
WW to Present at Goldman Sachs Global Staples Forum
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Mindy Grossman, [...]
Neon Therapeutics Reports First Quarter 2019 Financial Results and Provides Clinical Update
13/05/2019
Advancing a class-leading position in neoantigen-based therapies with ongoing progress across its multiple clinical-stage programs, pre-clinical pipeline and bioinformatics engine Expect to report in July top-line [...]
Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights
13/05/2019
Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD is Enrolling; Topline Data Expected First Half of 2020 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or [...]
Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019
13/05/2019
NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Retrophin Appoints Sandra E. Poole to Board of Directors
13/05/2019
Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the [...]
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results
13/05/2019
REDWOOD CITY, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
Rafael Pharmaceuticals Appoints Senior Vice President for Clinical Development and Operations
13/05/2019
Newark, NJ, May 13, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Mona M. [...]
Poseida Therapeutics Receives US FDA Orphan Drug Designation for P-BCMA-101 for the Treatment of Multiple Myeloma
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today [...]
111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019
13/05/2019
SHANGHAI, China, May 13, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the [...]
Exactus One World, LLC. Digs in for Initial Cultivation of 200 Acres in Southwest Oregon
13/05/2019
Cultivating the future of the area and industry, one seedling at a time, bringing CBD from the farm to the family DELRAY BEACH, Fla., May 13, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the “Company”), is [...]
Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator
13/05/2019
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis- [...]

Pages